FIFTH THIRD BANCORP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$35,205
-78.8%
393
-79.8%
0.00%
-100.0%
Q2 2023$165,853
+5.7%
1,948
+2.7%
0.00%0.0%
Q1 2023$156,894
+7.4%
1,896
+2.1%
0.00%0.0%
Q4 2022$146,053
+8.2%
1,857
+1.5%
0.00%0.0%
Q3 2022$135,000
+13.4%
1,8300.0%0.00%0.0%
Q2 2022$119,000
+4.4%
1,830
+1.7%
0.00%
Q1 2022$114,000
+11.8%
1,800
-6.8%
0.00%
Q4 2021$102,000
+50.0%
1,932
+100.2%
0.00%
Q3 2021$68,000
-41.4%
965
-44.6%
0.00%
-100.0%
Q2 2021$116,000
+673.3%
1,741
+1180.1%
0.00%
Q1 2021$15,000
+275.0%
136
+183.3%
0.00%
Q3 2020$4,000
-98.7%
48
-98.6%
0.00%
-100.0%
Q2 2020$308,000
+3.0%
3,440
+14.8%
0.00%0.0%
Q1 2020$299,000
+779.4%
2,997
+926.4%
0.00%
Q4 2019$34,000
-8.1%
2920.0%0.00%
Q3 2019$37,000
+5.7%
2920.0%0.00%
Q2 2019$35,000
+12.9%
292
-18.7%
0.00%
Q1 2019$31,000
-13.9%
3590.0%0.00%
Q4 2018$36,000
-25.0%
359
-15.1%
0.00%
Q3 2018$48,000
+11.6%
423
-11.7%
0.00%
Q2 2018$43,000
+22.9%
4790.0%0.00%
Q1 2018$35,000
+400.0%
479
+299.2%
0.00%
Q4 2017$7,000
-70.8%
120
-77.3%
0.00%
Q3 2017$24,000
+380.0%
529
+313.3%
0.00%
Q2 2017$5,000
+400.0%
128
+276.5%
0.00%
Q4 2016$1,0000.0%340.0%0.00%
Q3 2016$1,000
-80.0%
34
-76.1%
0.00%
Q4 2015$5,0000.0%142
+1.4%
0.00%
Q3 2015$5,000
+25.0%
140
+50.5%
0.00%
Q2 2015$4,0000.0%93
+1.1%
0.00%
Q1 2015$4,000
+33.3%
92
-3.2%
0.00%
Q3 2014$3,000
-72.7%
95
-69.3%
0.00%
Q2 2014$11,000
+10.0%
3090.0%0.00%
Q1 2014$10,000
-23.1%
309
+1.6%
0.00%
Q4 2013$13,000
-74.0%
304
-75.5%
0.00%
-100.0%
Q3 2013$50,000
+284.6%
1,242
+290.6%
0.00%
Q2 2013$13,0003180.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders